ABSI Absci Corp

8-K Current Report

Filed: March 6, 2026

Industrials

Services-Commercial Physical & Biological Research

Absci Corp (ABSI) 8-K current report filed with SEC EDGAR on March 6, 2026. This page provides AI-powered analysis of reported events and material disclosures, including results of operations, corporate governance changes, agreements, and other triggering events as disclosed under Form 8-K item codes.

Reported 8-K Items
3 items

Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure/Election of Directors or Officers
Item 7.01: Regulation FD Disclosure

AI Filing Analysis
8-K

Item 1.01 · Entry into a Material Definitive Agreement

• Absci updated indemnification agreements for all current directors and officers, effective March 6, 2026
• Key addition: company now covers separate counsel expenses for officers during a change-in-control scenario

+3 more insights

Item 5.02 · Departure/Election of Directors or Officers

• Chief Innovation Officer Andreas Busch retiring March 31, 2026; transitioning to 2-year scientific advisor role starting April 3, 2026
• Advisor compensation: $25,500 annual cash retainer plus 22,800 stock options and 5,800 RSUs under the 2021 Plan

+3 more insights

Item 7.01 · Regulation FD Disclosure

• Reg FD filing contains only standard liability disclaimer language — no actual business or financial information disclosed
• Investors should check attached exhibits (if any) for the underlying disclosed content

Get deeper insights on Absci Corp

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.